Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
This track focuses on the diagnostic challenges encountered in the spectrum of breast lesions, specifically from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS). With the increasing use of and detection techniques, the identification and accurate diagnosis of these lesions have become crucial for appropriate patient management. This track explores the complexities involved in distinguishing between ADH and DCIS, discussing the overlapping morphological features, immunohistochemical markers, and molecular characteristics that aid in differential diagnosis. The track also highlights the latest advancements in diagnostic tools, including genomic profiling and molecular testing, aiming to enhance diagnostic accuracy and guide optimal treatment strategies for patients with ADH and DCIS.
- Histopathological Evaluation: Morphological Criteria and Interpretation Challenges
- Radiological-Pathological Correlation: Enhancing Diagnostic Accuracy
- Biomarkers and Molecular Profiling: Identifying High-Risk Lesions
- Management Dilemmas: Overdiagnosis and Overtreatment
- Emerging Techniques and Technologies: Improving Diagnostic Precision
Related Conference of Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
November 24-25, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Barcelona, Spain
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ Conference Speakers
Recommended Sessions
- Benign Breast Lesions: Diagnosis, Management, and Surveillance
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
- Breast Imaging: Innovations in Radiology and Pathology Correlation
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning
- Immunohistochemistry and Biomarkers in Breast Pathology
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches
- Molecular Pathology: Unraveling Breast Cancer Subtypes
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies
Related Journals
Are you interested in
- Advancements in Early Detection and Screening - Euro Breast Cancer 2025 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- AI and Machine Learning in Cancer Care - CANCER2025 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Digital Health in Oncology - Euro Breast Cancer 2025 (France)
- Artificial Intelligence and Machine Learning in Oncology - Euro Cancer 2025 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Breast Cancer - Euro Cancer 2025 (France)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Euro Breast Cancer 2025 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Risk Reduction - Euro Breast Cancer 2025 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (France)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer Awareness and Survival - World Cancer-2025 (Spain)
- Cancer Case reports - Euro Cancer 2025 (France)
- Cancer Cell Biology & Genetics - World Cancer-2025 (Spain)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Epidemiology - World Cancer-2025 (Spain)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics and Epigenetics - Euro Cancer 2025 (France)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Immunology & Immunotherapy - World Cancer-2025 (Spain)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Nanotechnology - World Cancer-2025 (Spain)
- Cancer Personalized Medicine - Euro Cancer 2025 (France)
- Cancer Pharmacology - Euro Cancer 2025 (France)
- Cancer Pharmacology - World Cancer-2025 (Spain)
- Cancer Prevention and Lifestyle Interventions - Euro Cancer 2025 (France)
- Cancer Prevention and Risk Reduction - CANCER2025 (France)
- Cancer Research - Euro Cancer 2025 (France)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (France)
- Cancer Stem Cells and Tumor Heterogeneity - Euro Cancer 2025 (France)
- Cancer Survivorship and Long-Term Care - Euro Cancer 2025 (France)
- Cancer Therapy - Euro Cancer 2025 (France)
- Cancer Vaccines: Therapeutic and Preventive - Euro Cancer 2025 (France)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (France)
- Cancer: Psychological & Social factors - World Cancer-2025 (Spain)
- Cancers & Stem Cell therapy - World Cancer-2025 (Spain)
- Cancers Biomarkers - World Cancer-2025 (Spain)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Biopsy - World Cancer-2025 (Spain)
- Cancers Chemotherapy - World Cancer-2025 (Spain)
- Cancers Metabolomics - World Cancer-2025 (Spain)
- Cancers Metastasis - World Cancer-2025 (Spain)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Cancers Prevention & Research - World Cancer-2025 (Spain)
- Cancers Therapy & Treatments - World Cancer-2025 (Spain)
- Cancers Vaccines - World Cancer-2025 (Spain)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2025 (Spain)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (France)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell and Gene Therapy for Cancer - Euro Cancer 2025 (France)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (France)
- Combination Therapies and Synergistic Drug Protocols - Euro Cancer 2025 (France)
- Complementary & Alternate Methods and Cancer - World Cancer-2025 (Spain)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Spain)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Spain)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Spain)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Spain)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Spain)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Spain)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Spain)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Spain)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Spain)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Spain)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Spain)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Spain)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- Drug Development and Clinical Trials in Breast Cancer - Euro Breast Cancer 2025 (France)
- Drug Resistance in Cancer Therapy - Euro Cancer 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Spain)
- Early Detection and Screening Innovations - CANCER2025 (France)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Spain)
- Financial Toxicity and Healthcare Disparities in Cancer Care - Euro Cancer 2025 (France)
- Gene Editing & CRISPR in Cancer - World Cancer-2025 (Spain)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomics and Cancer Epigenetics - CANCER2025 (France)
- Global Disparities and Access to Breast Cancer Care - Euro Breast Cancer 2025 (France)
- Head and Neck Cancer - Euro Cancer 2025 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- HER2-Positive Breast Cancer: Latest Treatment Strategies - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and Cancer Vaccines - CANCER2025 (France)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Spain)
- Immunotherapy and Emerging Targeted Therapies - Euro Breast Cancer 2025 (France)
- Immunotherapy and Immune Checkpoint Inhibitors - Euro Cancer 2025 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Spain)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Liquid Biopsies and Circulating Tumor DNA (ctDNA) - Euro Cancer 2025 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Metastatic Breast Cancer: Quality of Life and Care - Euro Breast Cancer 2025 (France)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Spain)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Spain)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Neonatal & Pediatric Oncology - World Cancer-2025 (Spain)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Nursing and Care - World Cancer-2025 (Spain)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing and Patient Care - CANCER2025 (France)
- Oncolytic Viruses and Novel Biologic Therapies - Euro Cancer 2025 (France)
- Organ-defined Cancers - World Cancer-2025 (Spain)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Palliative Care and Quality of Life - CANCER2025 (France)
- Palliative Care and Quality of Life in Cancer Patients - Euro Cancer 2025 (France)
- Pediatric and Rare Cancers - Euro Cancer 2025 (France)
- Pediatric Oncology Innovations - CANCER2025 (France)
- Personalized and Precision Oncology - Euro Cancer 2025 (France)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (France)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2025 (Spain)
- Precision Medicine and Genomics in Breast Cancer - Euro Breast Cancer 2025 (France)
- Precision Oncology and Personalized Medicine - CANCER2025 (France)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (France)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychosocial Support and Survivorship in Breast Cancer - Euro Breast Cancer 2025 (France)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Therapy and Technological Innovations - Euro Breast Cancer 2025 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Radiomics and Imaging Innovations in Cancer Detection - Euro Cancer 2025 (France)
- Rare Cancers and Orphan Drugs - CANCER2025 (France)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Spain)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Spain)
- Skin Cancer - Cancer Science 2026 (UAE)
- Surgical Advances in Breast Cancer Management - Euro Breast Cancer 2025 (France)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (France)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (France)
- Targeted Therapy and Small Molecule Inhibitors - Euro Cancer 2025 (France)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Spain)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Spain)
- Telemedicine and Digital Health in Oncology - CANCER2025 (France)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Spain)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Triple-Negative Breast Cancer: Challenges and Innovations - Euro Breast Cancer 2025 (France)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Microenvironment and Cancer Metastasis - Euro Cancer 2025 (France)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2025 (Spain)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)